NCT05885607View on ClinicalTrials.gov

Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure

Enrolling by invitationOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

June 27, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Heart Failure NYHA Class IIHeart Failure NYHA Class IIIHeart Failure
Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

University of Pennsylvania

OTHER

NCT05885607 - Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure | Biotech Hunter | Biotech Hunter